Andy Chevigné and his staff, RTI-5152-12 is postulated to enhance the levels of opioid peptides that bind to classical opioid receptors while in the brain, leading to heightened painkilling action. The LIH-RTI study groups recognized a collaboration settlement and filed a joint patent software in December 2020. Scientific American https://benitoy702czu1.eqnextwiki.com/user